Description
SDS
References
Sample Datasheet
Info Request
Product Description
Innovative Grade US Origin Porcine Plasma
Innovative Research's Innovative Grade US Origin Porcine Plasma is used as a supplement to cell culture media. Swine Plasma provides a broad spectrum of macro molecules, carrier proteins for lipoid substances and trace elements, attachment and spreading factors, low molecular weight nutrients, and hormones and growth factors that promote cell growth and health. Be certain to maintain Good Cell Culture Practice, and maintain sterility of cultures that require media supplementation. Swine Plasma is ideal for investigators in Cancer, Immunology, and Cell Biology research.
This Innovative Research product is for in vitro research use only, is not to be consumed by animals or humans, and should be handled with general precaution as if capable of spreading infectious disease. Recommended storage is -20 degrees Celsius.
(1-16-12)
X Chen, CJ Peer, R Alfaro, T Tian, SD Spencer... - ... of Pharmaceutical and ..., 2012 - Elsevier
Drug-free heparinized porcine plasma was purchased from Innovative Research (Novi, MI). Drug-free heparinized human plasma was obtained from the National Institutes of Health Clinical Center Blood Bank (Bethesda, MD, USA). 2.2. Preparation of stock solutions and standards. (4-13-15)
ME Klegerman, AK Naji, KJ Haworth, Y Zou, E Golunski - of Liposome Research, 2015
... For release studies, one 5-mg BEV-ELIP or FITC-BEV-ELIP aliquot was reconstituted with 0.5 ml of nanopure water and added to 49.5 ml of PBS, human plasma (Innovative Research, Novi, MI) or porcine plasma (Innovative Research).
Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatographytandem mass spectrometry and its ...
X Chen, CJ Peer, R Alfaro, T Tian, SD Spencer... - ... of Pharmaceutical and ..., 2012 - Elsevier
Drug-free heparinized porcine plasma was purchased from Innovative Research (Novi, MI). Drug-free heparinized human plasma was obtained from the National Institutes of Health Clinical Center Blood Bank (Bethesda, MD, USA). 2.2. Preparation of stock solutions and standards. (4-13-15)
Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progression
ME Klegerman, AK Naji, KJ Haworth, Y Zou, E Golunski - of Liposome Research, 2015
... For release studies, one 5-mg BEV-ELIP or FITC-BEV-ELIP aliquot was reconstituted with 0.5 ml of nanopure water and added to 49.5 ml of PBS, human plasma (Innovative Research, Novi, MI) or porcine plasma (Innovative Research).
